We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

17 hedge funds and large institutions have $5.66M invested in Anixa Biosciences in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

31% more capital invested

Capital invested by funds: $4.32M → $5.66M (+$1.34M)

6% more funds holding

Funds holding: 16 → 17 (+1)

0.51% more ownership

Funds ownership: 5.86% → 6.38% (+0.51%)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
+$484K
2
UBS Group
UBS Group
Switzerland
+$183K
3
Morgan Stanley
Morgan Stanley
New York
+$71.7K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$14.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$9.53K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$15.1K
2
BlackRock
BlackRock
New York
-$12.1K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.78K
4
Wells Fargo
Wells Fargo
California
-$958

ANIX Hedge Fund Activity: Q1 2019 in Review

17 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2019, worth a combined $5.66M — up 31% from $4.32M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ANIX positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 4 trimmed.

The largest buyer was SG Americas Securities, opening a new position worth an estimated $484K. The largest seller was Bank of New York Mellon, cutting an estimated $15.1K.

  • 17 institutional investors held Anixa Biosciences (ANIX) as of Q1 2019, up from 16 in Q4 2018.
  • Funds reported $5.66M of Anixa Biosciences stock for Q1 2019, up 31% quarter-over-quarter.
  • 3 funds opened new Anixa Biosciences positions in Q1 2019 and 2 closed out, a net change of +1 holder.
  • The largest Anixa Biosciences buyer in Q1 2019 was SG Americas Securities, an estimated $484K added.
  • The largest Anixa Biosciences seller in Q1 2019 was Bank of New York Mellon, an estimated $15.1K sold.

Based on aggregated 13F filings for Q1 2019.